Wang L, Hensch N, Bondra K, Sreenivas P, Zhao X, Chen J, et al. SNAI2-Mediated Repression of BIM Protects Rhabdomyosarcoma from Ionizing Radiation. Cancer Res. 2021;81:5451-5463 pubmed publisher

Pomella S, Sreenivas P, Gryder B, Wang L, Milewski D, Cassandri M, et al. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma. Nat Commun. 2021;12:192 pubmed publisher

Jury D, Daugaard I, Sanders K, Hansen L, Agalliu D, Pedersen I. miR-151a enhances Slug dependent angiogenesis. Oncotarget. 2020;11:2160-2171 pubmed publisher

Stern J, Hibshman G, Hu K, Ferrara S, Costello J, Kim W, et al. Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers. Mol Cancer Res. 2020;18:1050-1062 pubmed publisher

Hartel I, Ronellenfitsch M, Wanka C, Wolking S, Steinbach J, Rieger J. Activation of AMP-activated kinase modulates sensitivity of glioma cells against epidermal growth factor receptor inhibition. Int J Oncol. 2016;49:173-80 pubmed publisher

Zirkel A, Lederer M, Stöhr N, Pazaitis N, Huttelmaier S. IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG). Nucleic Acids Res. 2013;41:6618-36 pubmed publisher

Liu J, Uygur B, Zhang Z, Shao L, Romero D, Vary C, et al. Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression. Prostate. 2010;70:1768-77 pubmed publisher

Gupta P, Kuperwasser C, Brunet J, Ramaswamy S, Kuo W, Gray J, et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet. 2005;37:1047-54 pubmed